LeFever A V, Truitt R L, Shih C C, Liepins A, Bortin M M
Transplantation. 1984 Apr;37(4):410-7. doi: 10.1097/00007890-198404000-00020.
The quantitative distribution of cytolytic T lymphocytes (CTL) generated in mixed leukocyte culture (MLC) and an interleukin-2 (IL-2)-dependent, CTL clone (WRL-A3) was investigated in various tissues of irradiated syngeneic and allogeneic mice. In addition, the ability of the WRL-A3 CTL clone to remain viable and retain antigen specificity following in vivo passage was evaluated. Injection i.v. of 51Cr-labeled cultured CTL resulted in: (1) extensive deposition of cells in the lungs with significantly more lymphocytes being recovered in allogeneic as compared with syngeneic lung tissue; (2) minimal accumulation in spleen with more in syngeneic than in allogeneic tissue; and (3) no localization in blood, femurs, thymus, or lymph nodes. The migration rate of cultured CTL exiting the lung during the first 4 hr was markedly faster in syngeneic than in allogeneic recipients and was directly associated with the distribution of these cells in other tissues at 24 hr. The WRL-A3 CTL clone recovered from irradiated syngeneic and allogeneic lung tissue at 1, 3, 6, 8, and 13 days after i.v. injection remained viable, even though no exogenous IL-2 was administered to the recipient mice. The recovered cells proliferated when recultured with IL-2, and retained their antigen specificity for Qed-1b target cells after in vivo passage. These findings indicate that restricted and undesirable tissue distribution, rather than impaired viability or loss of antigenic specificity, is the major obstacle to successful use of cultured CTL for adoptive immunotherapy of disseminated cancer.
研究了在混合白细胞培养(MLC)中产生的细胞毒性T淋巴细胞(CTL)以及白细胞介素-2(IL-2)依赖性CTL克隆(WRL-A3)在受照射的同基因和异基因小鼠各种组织中的定量分布。此外,还评估了WRL-A3 CTL克隆在体内传代后保持活力并保留抗原特异性的能力。静脉注射51Cr标记的培养CTL导致:(1)细胞大量沉积在肺中,与同基因肺组织相比,异基因肺组织中回收的淋巴细胞明显更多;(2)在脾脏中积累极少,同基因组织中的比异基因组织中的多;(3)在血液、股骨、胸腺或淋巴结中无定位。在最初4小时内从肺中逸出的培养CTL的迁移率在同基因受体中比在异基因受体中明显更快,并且与24小时时这些细胞在其他组织中的分布直接相关。静脉注射后1、3、6、8和13天从受照射的同基因和异基因肺组织中回收的WRL-A3 CTL克隆仍然存活,即使未向受体小鼠施用外源性IL-2。回收的细胞在用IL-2重新培养时增殖,并且在体内传代后对Qed-1b靶细胞保留其抗原特异性。这些发现表明,受限且不理想的组织分布,而非活力受损或抗原特异性丧失,是成功使用培养的CTL进行播散性癌症过继免疫治疗的主要障碍。